What Lion Point Capital, LP reported holding on Form 13F for the quarter ended Jun 30, 2026.
CIK 1643354 · Filed Aug 14, 2026
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
| 4.5K |
| ±0% |
| $1.5M |
| 7.1% |
MLTXMoonLake Immunotherapeutics | 67.5K | ±0% | $1.3M | 6.3% |
FENCFennec Pharmaceuticals Inc. | 112.4K | ±0% | $1.2M | 5.8% |
RPRXRoyalty Pharma plc | 21.4K | ±0% | $1.2M | 5.7% |
CMPSCOMPASS Pathways plc | 80K | ±0% | $1.1M | 5.4% |
MISTMilestone Pharmaceuticals Inc. | 820K | ±0% | $1.1M | 5.3% |
BNTCBenitec Biopharma Inc. | 62K | ±0% | $829.6K | 4% |
SNDXSyndax Pharmaceuticals Inc | 36K | ±0% | $787K | 3.8% |
BHVNBiohaven Ltd. | 51.7K | ±0% | $769.3K | 3.7% |
GERNGeron Corp | 578K | ±0% | $739.8K | 3.5% |
QUREuniQure N.V. | 14.7K | ±0% | $677.1K | 3.2% |
ARDXArdelyx, Inc. | 128.7K | ±0% | $656.1K | 3.1% |
LNTHLantheus Holdings, Inc. | 5.5K | ±0% | $610.2K | 2.9% |
IRONDisc Medicine, Inc. | 8.1K | ±0% | $592.4K | 2.8% |
SRPTSarepta Therapeutics, Inc. | 28.5K | ±0% | $512.1K | 2.4% |
HUMAHumacyte, Inc. | 650K | ±0% | $507.3K | 2.4% |
KURAKura Oncology, Inc. | 46K | ±0% | $504.6K | 2.4% |
VTRSViatris Inc | 27.7K | ±0% | $439.9K | 2.1% |
DYNDyne Therapeutics, Inc. | 18K | ±0% | $399.8K | 1.9% |
BBIOBridgeBio Pharma, Inc. | 5K | ±0% | $372.4K | 1.8% |
EWTXEdgewise Therapeutics, Inc. | 9.1K | ±0% | $369.7K | 1.8% |
PCRXPacira BioSciences, Inc. | 13.5K | ±0% | $342.5K | 1.6% |
RGNXREGENXBIO Inc. | 26.6K | ±0% | $318.7K | 1.5% |
RCKTRocket Pharmaceuticals, Inc. | 86K | ±0% | $294.1K | 1.4% |
JANXJanux Therapeutics, Inc. | 19K | ±0% | $291.8K | 1.4% |
MLYSMineralys Therapeutics, Inc. | 10.5K | ±0% | $283.3K | 1.4% |
GHRSGH Research PLC | 10.2K | ±0% | $274.2K | 1.3% |
MCRBSeres Therapeutics, Inc. | 31.6K | ±0% | $249.1K | 1.2% |
AZTAAzenta, Inc. | 9.7K | ±0% | $247.5K | 1.2% |
JSPRJasper Therapeutics, Inc. | 465K | ±0% | $195.8K | 0.9% |
INVAInnoviva, Inc. | 8.2K | ±0% | $186.2K | 0.9% |
IPHAInnate Pharma SA | 81.2K | ±0% | $149.3K | 0.7% |
ARQTArcutis Biotherapeutics, Inc. | 5.3K | ±0% | $137.7K | 0.7% |
SPRBSpruce Biosciences, Inc. | 1K | ±0% | $54K | 0.3% |
